Diversified Consumer Services
Company Overview of The University of Tokyo
Tokyo University is an educational institution.
Key Executives for The University of Tokyo
The University of Tokyo does not have any Key Executives recorded.
The University of Tokyo Key Developments
Vedanta Biosciences Announces Licence Agreement with Riken, the University of Tokyo and Azabu University
Mar 30 16
Vedanta Biosciences announced a licence agreement with RIKEN, the University of Tokyo and Azabu University for technology developed by RIKEN team leader and Vedanta co-founder and scientific advisory board member, Kenya Honda, M.D., Ph.D. The new technology has potential clinical applications in infectious disease, vaccine design and immuno-oncology. Vedanta also received a second patent issuance in Japan for key intellectual property. Under the terms of the agreement, Vedanta will collaborate with Dr. Honda's lab to investigate potential pharmaceutical candidates involving bacterial strains that activate immune cells in the human gut called Th17 cells. Th17 cells are a specialized group of immune cells that may help protect the body against infectious pathogens and are also a potential target in the treatment of cancer. Details on the technology - immune-boosting microbes isolated from the human gut - were published in October 2015 in the prestigious scientific journal Cell.1 In the published study, Honda and colleagues identified and isolated bacterial strains from humans that can induce Th17 cells and demonstrated that these strains induce Th17 responses by adhering to cells in the intestine.
The University of Tokyo Presents at 13th Annual BIO Asia International Conference 2016, Mar-16-2016 10:30 AM
Mar 11 16
The University of Tokyo Presents at 13th Annual BIO Asia International Conference 2016, Mar-16-2016 10:30 AM. Venue: Grand Hyatt, Tokyo, Japan. Speakers: Masuhiro Kato, Translational Research Initiative.
The University of Tokyo Presents at 14th Annual BIO Investor Forum, Oct-20-2015
Oct 16 15
The University of Tokyo Presents at 14th Annual BIO Investor Forum, Oct-20-2015 . Venue: Parc 55 Hotel, San Francisco, California, United States.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create
or control the content. For inquiries, please contact Capital IQ directly by clicking
Most Searched Private Companies
Sponsored Financial Commentaries